healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
droogendijk_2006_cohort_imatinib-mesylate-in-the-treatment-of-systemic-mastocytosis-phase-ii
2 findings
Protocol
medication-imatinib-mesylate-daily
Outcome
biomarker-hematology-hepatosplenomegaly-reduction
n
14
effect
20
attribution
40
Protocol
medication-imatinib-mesylate-daily
Outcome
skin-and-constitutional-symptom-reduction
n
14
effect
20
attribution
40